Final-Program-ATS-2023-AP.vp

SATURDAY • MAY 20

33

(CPET). We will combine didactic lectures with case-based instruction, small group discussion, and live demonstration of cardiopulmonary exercise testing. We will use a multidisciplinary team approach to facilitate case discussions including content experts, clinicians, physiologists, and pulmonary function laboratory medical directors from around the world. Chairing: T. Decato, MD, Torrance, CA M.C. Mccormack, MHS, MD, Baltimore, MD H.B. Rossiter, PhD, Torrance, CA 8:00 Blows and Flows: State of the Art in Spirometry S. Stanojevic, PhD, Halifax, Canada 8:30 Pump Up the Volume: Interpretation and Assessment of Lung Volumes A.S. Niven, MD, Rochester, MN 8:55 Insane in the Membrane: Demystifying DLCO T. Decato, MD, Torrance, CA 9:20 Turbulence Ahead: Updates in Bronchoprovocation Testing T.S. Hallstrand, MD, MPH, ATSF, Seattle, WA 10:00 Break 10:20 Don’t Forget About the Kids: Essentials in Pediatric Pulmonary Function Testing C.L. Ren, MD, MBA, ATSF, Philadelphia, PA 10:50 Putting It All Together: Small Group PFT Case Discussions 11:40 Lunch 12:10 Start Me Up: CPET Patient Setup and Demonstration C.D. Mottram, RRT, RPFT, Rochester, MN 1:10 Dancing in the Dark: CPET Reference Values H.B. Rossiter, PhD, Torrance, CA 1:40 Blinded Me With Science: CPET Data Display and Interpretation D.A. Kaminsky, MD, Burlington, VT 2:10 Break 2:30 What I Like About You: Typical CPET Responses Among Disease States K.E. Sietsema, MD, Torrance, CA 3:00 Express Yourself: CPET Small Group Cases T. Decato, MD, Torrance, CA R. Clay, MD, Clackamas, OR A.S. Niven, MD, Rochester, MN K. Jakharia, MBBS, MD, Chapel Hill, NC

CLINICAL • TRANSLATIONAL POSTGRADUATE COURSE

CME Credits Available: 6.25 MOC Points Available: 1.5

PG14 STATE OF THE ART: LUNG CANCER IN 2023 R Pre-registration and additional fees required. Attendance is limited. Member: $440 In-Training Member: $255 LMIC Member: $310 LMIC In-Training Member: $180 Non-Member: $540 In-Training Non-Member: $380 Assemblies on Thoracic Oncology; Clinical Problems 8:00 AM - 4:00 PM Marriott Marquis Washington Liberty Ballroom, Salon M (Level M4) Target Audience All providers caring for patients with lung nodules/lung cancer (pulmonologists, thoracic surgeons, radiation oncologists, NP/PAs).Those interested in the translational research being done in this field. Objectives At the conclusion of this session, the participant will be able to: • understand the racial and gender disparities related to lung cancer screening, diagnosis and treatment • understand recent developments in lung cancer diagnosis • understand recent advances in the treatment of lung cancer This course will provide a comprehensive review of topics in the evaluation and management of patients with lung cancer. We discuss recent developments in tobacco control, updated guidelines and practical tips for lung cancer screening, and minimally invasive diagnostic approaches for patients with lung nodules. The treatment of early stage, locally advanced and metastatic disease, highlighting novel/minimally invasive approaches as well as the use, and toxicities of immunotherapy will also be covered. Attention will be given to the impact of lung cancer on underrepresented populations as well as the rising incidence of lung cancer in non-smoking females. Interactive tumor boards will be held to highlight these topics and facilitate audience engagement. Chairing: D.J. Feller-Kopman, MD, Lebanon, NH N.T. Tanner, MD, MSCR, Charleston, SC 8:00 Introduction D.J. Feller-Kopman, MD, Lebanon, NH 8:05 Engaging the Community in Lung Cancer Screening & Tobacco Cessation P. Galiatsatos, MD, Baltimore, MD 8:30 Addressing Disparities in Lung Cancer: The Rural Population R. Hasson, MD, Lebanon, NH

ATS 2023 • Washington, DC